Jagsonpal Pharmaceuticals Share Price

Small Cap | Pharmaceuticals and health care | NSE: JAGSNPHARM | BSE: 507789

₹204.60 image-4.60 (-2.20 %)

Last Updated: 13 Mar 2025 12:00 AM

Technicalsimage BEARISHimage

Overview

Open (₹) 210.00

High (₹) 211.45

Low (₹) 202.70

Prev. Close (₹) 209.20

Volume 8,210

VWAP (₹) 206.36

ROCE (%) 15.50

Industry P/E 43.95

TTM P/E 25.96

P/B Ratio 2.89

Market Cap (₹) Cr.1,360.67

Dividend Yield (%)2.44

EPS (₹) 8.46

ROE11.94%

Sales Growth (%) -11.83

Profit Growth (%)-15.94

Day Range

211.45211.45

L
H

52 Week Range

108.02328.02

L
H

Historical Returns

Returns (6M)

24.91 %

Returns (1Y)

72.31 %

Returns (3Y)

107.42 %

Returns (5Y)

2444.78 %

Returns (6M)

24.91 %

Returns (1Y)

72.31 %

Returns (3Y)

107.42 %

Returns (5Y)

2444.78 %

SWOT Analysis

  • Growth in Net Profit Margin (QoQ)
  • Growth in Annual Net Profit with increasing Profit Margin (YoY)
  • Strong long-term momentum: Price above long-term moving averages (EMA_200)

Technicals
info_icon

Technical Rating

Trendimage  BEARISH
Moving Averages
Technical Indicators
Bullish
Bullish

RSI 36.89

MFI 38.41

ATR 17.99

Commodity Channel Index -106.89

ROC125 28.24

ROC21 -17.20

Williams %R -94.13

Resistance & Support
info_icon

TypeResistance 1 Resistance 2 Resistance 3 PP Support 1 Support 2 Support 3
Current210.50214.50218.65206.35202.35198.20194.20
Week Ago226.01232.58237.06221.53214.96210.48203.91
Month Ago237.50252.30271.05218.75203.95185.20170.40

EMA & SMA
info_icon

204.60

Current Price

EMA & SMApin

Bullish Moving Averages

2

Bearish Moving Averages

18

5 Day 215.50


9 Day 216.36


10 Day 219.12


12 Day 219.89


14 Day 224.11

20 Day 234.06


26 Day 234.44


50 Day 240.10


100 Day 232.87


200 Day 190.30

Deals & Announcements

Bulk and Block Deals

Client NameDeal TypeActionDateAvg. PriceQuantityExchange
ORION STOCKS LTDbulkSell27 May, 2021₹102.2064,674BSE
ORION STOCKS LTDbulkBuy27 May, 2021₹100.981,35,114BSE
ORION STOCKS LTDbulkSell25 Mar, 2021₹81.351,07,088BSE
ORION STOCKS LTDbulkBuy25 Mar, 2021₹79.671,44,875BSE
ORION STOCKS LTDbulkSell24 Mar, 2021₹83.251,44,903BSE
ORION STOCKS LTDbulkBuy24 Mar, 2021₹81.521,80,401BSE
ORION STOCKS LTDbulkSell22 Mar, 2021₹80.081,16,406BSE
ORION STOCKS LTDbulkBuy22 Mar, 2021₹78.491,53,393BSE
ORION STOCKS LTDbulkSell19 Mar, 2021₹78.061,34,220BSE
ORION STOCKS LTDbulkBuy19 Mar, 2021₹77.201,16,562BSE

Insider Trading

DateNameActionAvg. PriceQuantityDeal Value
29 Jun, 2022Rajpal Singh Kochhar for and on behalf of Aresko Progressive Private Limited acting in capacity as a trustee of the Aresko Progressive Trust; and as the representative partner of J&P Investments PartnershipDisposal₹235.001,14,55,500BSE
28 Feb, 2022Rajpal Singh Kochhar for and on behalf of Aresko Progressive Private Limited acting in capacity as a trustee of the Aresko Progressive Trust; and as the representative partner of J&P Investments PartnershipDisposal₹238.122,25,737BSE
25 Feb, 2022Rajpal Singh Kochhar for and on behalf of Aresko Progressive Private Limited acting in capacity as a trustee of the Aresko Progressive Trust; and as the representative partner of J&P Investments PartnershipDisposal₹234.151,99,763BSE
04 Jan, 2021INDERPAL SINGH KOCHHARAcquisition₹72.0617,642BSE
24 Dec, 2020INDERPAL SINGH KOCHHARAcquisition₹67.123,000BSE
23 Dec, 2020INDERPAL SINGH KOCHHARAcquisition₹67.0615,752BSE
21 Dec, 2020INDERPAL SINGH KOCHHARAcquisition₹69.875,625BSE
18 Dec, 2020INDERPAL SINGH KOCHHARAcquisition₹69.123,366BSE
15 Dec, 2020INDERPAL SINGH KOCHHARAcquisition₹66.846,000BSE
15 Dec, 2020INDERPAL SINGH KOCHHARAcquisition₹67.623,000BSE

Corporate Actions

Announcement DateSubjectEx - DateRecord Date
23 Oct, 2024Stock split from Rs. 5/- to Rs. 2/-.08 Jan, 202508 Jan, 2025
21 May, 2024Rs.5.0000 per share(100%)Final Dividend06 Sept, 202406 Sept, 2024
23 May, 2023Rs.5.0000 per share(100%)Dividend21 Aug, 202321 Aug, 2023
19 Oct, 2021Rs.4.0000 per share(80%)Interim Dividend29 Oct, 202101 Nov, 2021

Announcements

DateSourceDetail
13 Mar, 2025NSE IndiaJAGSONPAL PHARMACEUTICALS LIMITED has informed the Exchange regarding Allotment of Securities
13 Mar, 2025NSE IndiaJAGSONPAL PHARMACEUTICALS LIMITED has informed the Exchange about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent
13 Mar, 2025NSE IndiaJagsonpal Pharmaceuticals Limited has informed the Exchange regarding ''Allotment of Equity Shares under the Jagsonpal Pharmaceuticals Limited Employee Stock Option Plan, 2022 ( JPL ESOP 2022 )''.
13 Mar, 2025BSE IndiaAllotment of Equity Shares under the Jagsonpal Pharmaceuticals Limited Employee Stock Option Plan, 2022
13 Mar, 2025NSE IndiaJagsonpal Pharmaceuticals Limited has informed the Exchange regarding ''Intimation under Regulation 30(5) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (Listing Regulations)''.
13 Mar, 2025BSE IndiaWe wish to inform you that consequent to the appointment of Mr. Pratham Rawal as Company Secretary, the board of directors have approved changes in KMPs authorized for purpose of determining materiality of an event or information and for the purpose of making disclosures to stock exchange (s) under the Listing Regulations.
13 Mar, 2025NSE IndiaJagsonpal Pharmaceuticals Limited has informed the Exchange about Change in Company Secretary/Compliance Officer
13 Mar, 2025BSE IndiaAppointment of Mr. Pratham Rawal as Company Secretary and Compliance Officer of the Company w.e.f. March 13, 2025
03 Mar, 2025NSE IndiaJAGSONPAL PHARMACEUTICALS LIMITED has informed the Exchange about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent
03 Mar, 2025NSE IndiaJagsonpal Pharmaceuticals Limited has informed the Exchange about Change in Company Secretary/Compliance Officer

Board Meetings

PurposeDetailsMeeting DateBroadcast Date
Quarterly Results--16 Jan, 202522 Jan, 2025
Quarterly Results & Stock Split--17 Oct, 202423 Oct, 2024
Quarterly Results--01 Aug, 202407 Aug, 2024
Audited Results & Final Dividend--14 May, 202420 May, 2024
Quarterly Results--30 Jan, 202402 Feb, 2024
Quarterly Results--27 Oct, 202303 Nov, 2023
Quarterly Results--27 Jul, 202302 Aug, 2023
Audited Results & Dividend--16 May, 202323 May, 2023
Quarterly Results--01 Feb, 202308 Feb, 2023
Quarterly Results--04 Nov, 202209 Nov, 2022

Share Holding Pattern

Loading...

Loading...

Owner NameDec, 2024Sept, 2024Jun, 2024Mar, 2024Dec, 2023

About Jagsonpal Pharmaceuticals

Jagsonpal Pharmaceuticals is a Public Limited Listed company incorporated on 17/08/1978 and has its registered office in the State of Delhi, India. Company’s Corporate Identification Number(CIN) is L74899DL1978PLC009181 and registration number is 009181. Currently Company is involved in the business activities of Manufacture of allopathic pharmaceutical preparations. Company’s Total Operating Revenue is Rs. 208.70 Cr. and Equity Capital is Rs. 13.22 Cr. for the Year ended 31/03/2024. Read More

Parent Organisation

Not Applicable

Founded

1978

Managing Director

Mr. Manish Gupta

NSE Symbol

JAGSNPHARM

Jagsonpal Pharmaceuticals Management

NameDesignation
Mr. Rajpal Singh KochharChairman Emeritus
Mr. Harsha RaghavanChairman & Non-Exe.Director
Mr. Manish GuptaManaging Director
Mr. Prithipal Singh KochharNon Executive Director
Mr. Debasis Bikash NandyIndependent Director
Ms. Radhika Madhukar DudhatIndependent Director
Ms. Pallavi Dinodia GuptaIndependent Director

Peer Comparison

StocksMarket CapMarket Price52 Week Low-High
Sun Pharmaceutical Industries₹4,03,916.05₹1,683.45 image
₹1,676.85(0.39%)
₹1,376.750 - ₹1,960.200
Divi's Laboratories₹1,49,205.29₹5,620.45 image
₹5,667.15(-0.82%)
₹3,350.050 - ₹6,448.750
Cipla₹1,18,065.23₹1,461.90 image
₹1,454.30(0.52%)
₹1,317.600 - ₹1,702.000
Torrent Pharmaceuticals₹1,03,430.62₹3,056.05 image
₹3,096.50(-1.31%)
₹2,488.000 - ₹3,589.950
Dr. Reddy's Laboratories₹92,453.48₹1,107.95 image
₹1,105.15(0.25%)
₹1,093.000 - ₹1,420.200

FAQs on Jagsonpal Pharmaceuticals

What is the share price of Jagsonpal Pharmaceuticals?

The share price of Jagsonpal Pharmaceuticals on 13 Mar, 2025 is ₹ 204.60.

What is 52W high and 52W low share price of Jagsonpal Pharmaceuticals?

The highest and lowest 52W share prices of Jagsonpal Pharmaceuticals are ₹ 328.020 and ₹ 108.020

What is the market cap of Jagsonpal Pharmaceuticals?

The market capitalization of Jagsonpal Pharmaceuticals as of 13 Mar, 2025 is ₹ 1,360.67 Crores

What is the P/E ratio of Jagsonpal Pharmaceuticals?

The current P/E ratio of Jagsonpal Pharmaceuticals as of 13 Mar, 2025 is 43.95

What is the PB ratio of Jagsonpal Pharmaceuticals?

The PB ratio of Jagsonpal Pharmaceuticals as of 13 Mar, 2025 is 2.89

Top Gainers

₹6.97image

₹5.81 (0.20%)

₹194.70image

₹162.25 (0.20%)

Top Losers

₹13.75image

₹135.15 (-0.90%)

₹9.60image

₹12.00 (-0.20%)

₹9.80image

₹93.55 (-0.90%)

₹0.99image

₹4.77 (-0.79%)

Market Indices

Sensex

₹73,828.91image

₹74,029.76 (0.00%)

Source : Dion Global Solutions Limited